Indtræder denne ændring, skal den mest definitive test for antracyclin myokardiel skade, en endomyokardiel biopsi, overvejes.
If this change occurs, the most definitive test for anthracycline myocardial injury, i. e., endomyocardial biopsy, must be considered.